SCHEMBL13087253

SCHEMBL13087253

CS(=O)(=O)N1CCC(COc2cc(-c3cccc(C#N)c3)cc3ccncc23)C1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 3/20 0.46
CHUK O15111 3/20 0.46
SCN9A Q15858 1/20 0.40
CCNT1 O60563 1/20 0.39
CDK9 P50750 1/20 0.39
IRAK1 P51617 3/20 0.38
BRD4 O60885 1/20 0.38
IRAK4 Q9NWZ3 1/20 0.38
MCHR1 Q99705 2/20 0.37
PDE4D Q08499 1/20 0.37
VCP P55072 1/20 0.36
USP30 Q70CQ3 1/20 0.36
HSD11B1 P28845 1/20 0.35
CYP4F2 P78329 2/20 0.35
CYP4A11 Q02928 2/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
MET P08581 1/20 0.35
NQO2 P16083 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13087326 0.95 IKBKB (0.41) IKBKBCHUKSCN9ACCNT1CDK9
SCHEMBL13087718 0.84 IKBKB (0.46) IKBKBCHUKSCN9ACCNT1CDK9
SCHEMBL2424122 0.84 IKBKB (0.45) IKBKBCHUKSCN9ABRD4PDE4D
SCHEMBL13087406 0.83 BRD4 (0.40) IKBKBCHUKSCN9ABRD4PDE4D
SCHEMBL13087338 0.81 CCNT1 (0.40) IKBKBCHUKCCNT1CDK9IRAK1
Bicarbonate SCHEMBL15158107 0.80 DGAT2 (0.43) IKBKBCHUKSCN9ABRD4PDE4D
Bicarbonate SCHEMBL15158110 0.80 DGAT2 (0.43) IKBKBCHUKSCN9ABRD4PDE4D
SCHEMBL13087361 0.80 ROCK2 (0.46) CCNT1CDK9IRAK1IRAK4MCHR1
SCHEMBL13087305 0.80 ROCK2 (0.46) CCNT1CDK9IRAK1IRAK4MCHR1
SCHEMBL13087449 0.79 CCNT1 (0.41) IKBKBCHUKSCN9ACCNT1CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8299055-B2 8-substituted isoquinoline derivative and the use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2012-10-30 US disclosed
US-8299055-B2 8-substituted isoquinoline derivative and the use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2012-10-30 US disclosed
US-20100261701-A1 8-Substituted isoquinoline derivative and the use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2010-10-14 US disclosed
US-20100261701-A1 8-Substituted isoquinoline derivative and the use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2010-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100261701-A1 8-Substituted isoquinoline derivative and the use thereof RELA, NFKBIA, NFKB2 IKBKB 7/4885CHUK 17/4885SCN9A 3038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.